Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apparent Cytotoxicity and Intrinsic Cytotoxicity of Lipid Nanomaterials Contained in a COVID-19 mRNA Vaccine
Gabriele Segalla
International Journal of Vaccine Theory Practice and Research (2023) Vol. 3, Iss. 1, pp. 957-972
Open Access | Times Cited: 10

Showing 10 citing articles:

Innovations, Challenges, and Future Prospects for Combination Vaccines Against Human Infections
Munazza Fatima, Kee‐Jong Hong
Vaccines (2025) Vol. 13, Iss. 4, pp. 335-335
Open Access
An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease
Jianglong Li, Haiyan Long, Shaoyi Chen, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 52-52
Open Access
Adjuvant Activity and Toxicological Risks of Lipid Nanoparticles Contained in the COVID‑19 “mRNA Vaccines”
Gabriele Segalla
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1085-1102
Open Access | Times Cited: 3
The Efficacy and Safety of Polyethylene Glycol Cholesterol- and Tocopherol Polyethylene Glycol 1000 Succinate-Modified Transforming Growth Factor β1 Small Interfering RNA Lipid Nanoparticles in the Treatment of Paclitaxel-Resistant Non-Small-Cell Lung Cancer
Zhaowu Zeng, Xianglong Zeng, Xinyi Li, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 75-75
Open Access | Times Cited: 2
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature
Patrizia Gentilini, Janci C. Lindsay, Nafuko Konishi, et al.
(2024)
Open Access
A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature
Patrizia Gentilini, Janci C. Lindsay, Nafuko Konishi, et al.
(2024)
Open Access
Autoantibodies Targeting G-Protein-Coupled Receptors and RAS-Related Molecules in Post-Acute COVID Vaccination Syndrome: A Retrospective Case Series Study
Mauro Mantovani, Paolo Bellavite, Sergio Fazio, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2852-2852
Open Access
Lung-Selective Delivery of mRNA-Encoding Anti-MERS-CoV Nanobody Exhibits Neutralizing Activity Both In Vitro and In Vivo
Yuhang Zhang, Chongyu Tian, Xinyang Yu, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1315-1315
Open Access
Page 1

Scroll to top